Skip to main content
. 2020 Nov 27;12(12):3541. doi: 10.3390/cancers12123541

Figure 8.

Figure 8

Schematic representation of the workflow for assessing the performance of the ddPCR assays for detecting TERT promoter mutations in urine of bladder cancer patients and controls in two independent cohorts.